Multidisciplinary management, standard of care, therapeutic targets and future perspectives.

The ESMO Preceptorship on Prostate Cancer 2026: Zurich is a specialized educational programme designed for oncology professionals seeking advanced expertise in the diagnosis and treatment of prostate cancer. Organised by the European Society for Medical Oncology and hosted in Zurich, this preceptorship offers an intensive learning experience focused on state-of-the-art clinical practice, multidisciplinary care, and the latest scientific developments in prostate cancer management.

This highly interactive course combines expert-led lectures, real-world case discussions, and collaborative learning sessions to enhance clinical decision-making and improve patient outcomes.